Author:
Wernicke A. Gabriella,Mahase Sean S.,Schwartz Theodore H.
Publisher
Springer International Publishing
Reference78 articles.
1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75:5–14.
2. Nichols EM, Patchell RA, Regine WF, Kowk Y. Palliation of the brain and spinal cord metastases. In: Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Perez and Brady’s principles of radiation oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1765–72.
3. Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol. 1988;45:741–4.
4. Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11(5):352–63.
5. Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, Moore B, Brisbane I, Ardron D, Holt T, Morgan S, Lee C, Waite K, Bayman N, Pugh C, Sydes B, Stephens R, Parmar MK, Langley RE. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet. 2016;388(10055):2004–14.